p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions

Alessia Garufi; Giuseppa Pistritto; Silvia Baldari; Gabriele Toietta; Mara Cirone; Gabriella D’Orazi

doi:10.1186/s13046-017-0596-z

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

This page is a summary of: p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions, Journal of Experimental & Clinical Cancer Research, September 2017, Springer Science + Business Media,
DOI: 10.1186/s13046-017-0596-z.
You can read the full text:

Read

Resources

Open Access version
p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
Open Access Version

Contributors

The following have contributed to this page

Dr Gabriele Toietta
IRCCS Regina Elena National Cancer Institute

p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions

Resources